Although both Novel Retatrutide and Hyalgan Durolane target articular soreness, their approaches of action are significantly different . Retatrutide is a combined receptor influencing the GLP-1 receptor and GIP , primarily used for metabolic regulation, which may secondarily lessen inflammation